🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› EU
Clinical trial register · European Union · CTIS

Recently authorised EU trials

The most recently authorised trials on the EU Clinical Trials Information System (CTIS), the single register for every trial run under the EU Clinical Trials Regulation (536/2014). CTIS holds a far larger historical archive than any one list can usefully show — this register states both numbers rather than picking one.

Download CSV
Source: EMA Clinical Trials Information System (CTIS). Showing the 2500 most recently authorised of 12445 total CTIS records — a stated recency window, not the full historical archive. Synced 21 Sep 2026, 03:16 UTC
2500
Shown in this register
most recently authorised
12,445
Total on CTIS
full historical archive
745
Phase III
within the shown window
Top member states
Spain 1023 France 890 Germany 861 Italy 742 Poland 587 Netherlands 524
Narrow the registerReset
Phase
Phase I 558 Phase I/II 214 Phase II 726 Phase III 745 Phase IV 257
Lead sponsor
AstraZeneca AB 60 Assistance Publique Hopitaux De Paris 49 Merck Sharp & Dohme LLC 48 Pfizer Inc. 45 Novo Nordisk A/S 42
Member state
Spain 1023 France 890 Germany 861 Italy 742 Poland 587 Netherlands 524 Belgium 426 Czechia 327
All 28 states
558 of 2500 shown studies
Download
Phase
Study
Lead sponsor
Area
Member states
Decision
Phase I
A Phase I Study to Evaluate ELA822
2025-524911-34-00Healthy Volunteers
Electra Therapeutics Inc.
Immune System Diseases
Austria
02/08/2026
Phase I
A Randomised, Placebo‑Controlled Trial to Assess Effect of IMU‑838 on QT/QTc
2026-526859-54-00Multiple sclerosis
Immunic AG
Nervous System Diseases
Belgium
31/07/2026
Phase I
A study to test how well different doses of BI 3822971 are tolerated by people with advanced cancer (solid tumours)
2026-525785-22-00solid tumours
Boehringer Ingelheim International GmbH, Boehringer Ingelheim Espana S.A.
Neoplasms
Spain
31/07/2026
Phase I
Whole body HER2 quantification with 89Zr-Trastuzumab PET/CT to asses Zr-trastuzumab accumulation in HER2-mutated and HER2-overexpressing metastatic non-small cell lung cancer
2026-525568-17-00HER2 mutation positive NSCLC
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting
Pathological Conditions, Signs and Symptoms
Netherlands
30/07/2026
Phase I
Nav 1.8 and 1.7 combo trial
2026-526867-39-00Pain
Niroda Therapeutics Inc.
Nervous System Diseases
Netherlands
30/07/2026
Phase I
Bioequivalence of Tramadol retard 200 mg Prolonged-Release Tablets in Healthy Participants Under Fasting Conditions
2026-525836-41-00Not applicable (submitted trial is a bioavailability trial …
Laboratorios Cinfa S.A.
Nervous System Diseases
Czechia
30/07/2026
Phase I
Study to assess the plasma concentration of rilzabrutinib given as a tablet to adult participants with severe renal impairment compared to matched participants with normal renal function
2026-525707-27-00Renal Impairment
Sanofi-Aventis Recherche & Developpement
Immune System Diseases
Germany
30/07/2026
Phase I
A Phase 1a/1b, multicenter, open-label study evaluating the safety, tolerability, pharmacokinetics, and preliminary antitumor activity of PLN-101095 alone and in combination with pembrolizumab in adults with advanced or metastatic solid tumors following progression on immune checkpoint inhibitor therapy
2026-526116-36-00Advanced or metastatic solid tumours
Pliant Therapeutics Inc.
Neoplasms
Spain
29/07/2026
Phase I
An Open-label Phase 1 Study in Healthy Adult Participants to Investigate the Effect of Itraconazole on the Blood Levels of Engasertib
2026-526311-11-00This clinical trial is performed in healthy participants; t…
Vaderis Therapeutics AG
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Germany
29/07/2026
Phase I
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination with Bevacizumab in Adult Participants with Ovarian Cancer
2025-522209-40-00Ovarian Cancer
AbbVie Deutschland GmbH & Co. KG
Neoplasms
Portugal, Denmark, Spain, France
27/07/2026
Phase I
A Phase 1 Study of PRT12396 in Participants with Select Myeloproliferative Neoplasms
2026-525484-40-00Post-Essential Thrombocythemia Myelofibrosis, Post-Polycyth…
Prelude Therapeutics Inc.
Neoplasms
Italy, France, Spain
27/07/2026
Phase I
A first-in-human, randomized, double-blind, placebo-controlled, 3-part study assessing the safety, tolerability, pharmacodynamics and pharmacokinetics of GL0071 after single and repeated ascending subcutaneous doses in healthy normal weight, overweight and obese participants, as well as a 12-week treatment randomized, double blind, placebo-controlled exploratory Proof-of-Concept study in overweight and obese participants.
2025-524233-45-00Type 2 diabetes mellitus, Overweight
Sun Pharmaceutical Industries Limited
Nutritional and Metabolic Diseases
Belgium
27/07/2026
Phase I
A clinical trial of MK-3868 in healthy participants (MK-3868-001)
2026-526674-17-00Malaria
Merck Sharp & Dohme LLC
Parasitic Diseases
Belgium
27/07/2026
Phase I
A study in healthy people to measure how different doses of verducatib affect the heart
2026-525813-30-00Healthy volunteer trial
Boehringer Ingelheim International GmbH
Not possible to specify
Germany
27/07/2026
Phase I
Immune Cell Therapy for People with Early, Active Multiple Sclerosis
2025-522409-39-00Newly diagnosed highly-active Multiple Sclerosis
Medizinische Hochschule Hannover
Nervous System Diseases
Germany
24/07/2026
Phase I
161Tb-labeled Gastrin Analogue - A Novel Tool for Precision Treatment of Advanced Medullary Thyroid Cancer
2025-524951-30-00Thyroid cancer
Uniwersytet Jagiellonski Collegium Medicum
Diagnosis
Poland
24/07/2026
Phase I
A Study to Evaluate the Safety and Activity of an Inhaled Investigational Drug (RO7616605) in Healthy Volunteers and Participants With COPD
2025-525042-22-00Chronic Obstructive Pulmonary Disease (COPD) and Chronic Br…
Genentech Inc.
Respiratory Tract Diseases
Germany
23/07/2026
Phase I
An unblinded, single arm, pilot observational study to test the safety, tolerability, immunogenicity and the biological effects of TRB-001 vaccination in individuals who have previously undergone aSyn immunotherapy
2026-526294-42-00Parkinson's disease
Tridem Bioscience FlexCo
Nervous System Diseases
Austria
22/07/2026
Phase I
Tarlatamab Before and After Surgery for Recurrent High-Grade Glioma
2025-524359-30-00surgically resectable recurrent high-grade glioma
Vall D Hebron Institute Of Oncology
Neoplasms
Spain
22/07/2026
Phase I
Phase 1/1b Study of BMS-986463 in Advanced Malignant Tumors
2025-523067-38-01Advanced Malignant Tumors; High-grade Serous Ovarian Carcin…
Bristol-Myers Squibb Services Unlimited Company
Neoplasms
Spain, France, Italy
21/07/2026
Phase I
A more sustainable perioperative treatment regimen for gastroesophageal cancer —replacing 5-FU with capecitabine within the FLOT regimen
2026-526209-13-00Gastric Cancer, Esophageal cancer
Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
Neoplasms
Netherlands
21/07/2026
Phase I
Study of MX006 in Patients With Advanced and/or Metastatic Tumors known to express B7-H3
2025-524929-41-00Advanced Solid Tumor Types Known to Express B7-H3
Myricx Pharma Limited
Neoplasms
Spain
20/07/2026
Phase I
A study comparing the new drugs PG511/PG521/PG531 produced by Celon Pharma SA with the drug PG203 in healthy volunteers.
2025-524936-20-00Treatment of psychotic disorders like schizophrenia Treatme…
Celon Pharma S.A.
Mental Disorders
Poland
20/07/2026
Phase I
Bioequivalence study of Vitamin D3 Pharma Patent 20,000 IU and the Vigantol 20,000 IU oral drops solutions and assessment of bioavailability in healthy volunteers
2026-526224-48-02Healthy volunteers
Pharma Patent Kft.
Not possible to specify
Hungary
17/07/2026
Phase I
A single center, randomized, controlled trial in healthy volunteers using dermal open flow microperfusion to assess cutaneous BE of two doxepin hydrochloride creams
2026-526078-18-00No medical condition is being investigated in this clinical…
Medical University Of Graz
Not possible to specify
Austria
17/07/2026
Rows per page Showing 76–100 of 558
Previous 2 3 4 5 6 Next
Cite this view

Priya Life Science (2026). EU Clinical Trials Register (CTIS), filtered. Derived from the EMA Clinical Trials Information System. Retrieved 21 September 2026. https://priyalifescience.com/clinical-trials-europe

Query this register directly
GET /api/export.php?register=trials-eu&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. Looking for Irish sites? See the Ireland, UK or USA registers. For approved medicines, see the EMA Approvals Tracker.